Title: Self-ordering of metallogrid complexes via directed hydrogen-bonding.
Journal: Dalton transactions (Cambridge, England : 2003) 20121207
Title: Suppressive effects of liquid crystal compounds on the growth of U937 human leukemic monocyte lymphoma cells.
Journal: Cancer cell international 20120101
Title: Identification of specific and semi-specific SIRT inhibitors through computer-aided studies.
Journal: Aging 20110901
Title: Suppressive effects of liquid crystal compounds on the growth of the A549 human lung cancer cell line.
Journal: Investigational new drugs 20110801
Title: Molecular dynamics simulations of the liquid-crystal phases of 2-(4-butyloxyphenyl)-5-octyloxypyrimidine and 5-(4-butyloxyphenyl)-2-octyloxypyrimidine.
Journal: Physical review. E, Statistical, nonlinear, and soft matter physics 20100401
Title: Design of liquid crystals with 'de Vries-like' properties: frustration between SmA- and SmC-promoting elements.
Journal: Journal of the American Chemical Society 20100113
Title: Design and Synthesis of Imidazopyrimidine Derivatives as Potent iNOS Dimerization Inhibitors.
Journal: The open medicinal chemistry journal 20090101
Title: 2-Phenylpyrimidine skeleton-based electron-transport materials for extremely efficient green organic light-emitting devices.
Journal: Chemical communications (Cambridge, England) 20081130
Title: Synthesis and anticancer activity of cyclopalladated complexes containing 4-hydroxy-acridine.
Journal: Journal of inorganic biochemistry 20060901
Title: [Effects of liquid crystal-related compounds on human megakaryocytopoiesis and thrombopoiesis].
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20060601
Title: Co3(RL)2(hfac)6 ladder complex of 5-[4-(N-tert-butyl-N-aminoxyl)phenyl]pyrimidine.
Journal: Inorganic chemistry 20060320
Title: Chirality transfer in ferroelectric liquid crystals.
Journal: Accounts of chemical research 20011101
Title: [Selective inhibition of tyrosine kinases - a new therapeutic principle in oncology].
Journal: Onkologie 20010901
96363-20-1 | 3-((tert-Butoxycarbonyl)amino)-3-(4-methoxyphenyl)propanoic acid | AA003I3W | MFCD02090694